Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C.
Harry Rubin-FalconeIan FoxEmily HirschfeldLynn AngRodica Pop-BusuiJoyce M LeeJenna WiensPublished in: Journal of diabetes science and technology (2021)
Pediatric patients who frequently modify their basal insulin exhibit somewhat better clinical outcomes, although the magnitude by which their basal amount is changed does not contribute to this effect.